![Frank W. Oertel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank W. Oertel
Direttore/Membro del Consiglio presso BioAgency AG
Posizioni attive di Frank W. Oertel
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioAgency AG
![]() BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Frank W. Oertel
Precedenti posizioni note di Frank W. Oertel
Società | Posizione | Inizio | Fine |
---|---|---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Fondatore | 01/04/2002 | - |
Statistiche
Distribuzione geografica
Germania | 3 |
Posizioni
Director/Board Member | 1 |
Founder | 1 |
Settori
Finance | 2 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
BioAgency AG
![]() BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany. | Finance |
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
- Borsa valori
- Insiders
- Frank W. Oertel
- Esperienza